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Cpt-induced autophagy blocks cell death, leading to the promotion of G 2 /m phase arrest
To determine the effect of CPT on cell viability and proliferation, human prostate cancer LNCaP and DU145 cells were treated with different concentrations of CPT and incubated for 24 h. Cell viability and growth were determined by MTT and trypan blue exclusion assays. As shown in Supplementary Figure 1A and 1B, CPT treatment significantly decreased cell viability and proliferation, respectively. However, apoptotic annexin-V + populations were not detected when LNCaP cells were treated with CPT for 24 h (Supplementary Figure 1C) . Similarly, light microscopy showed that apoptotic shrinkage occurs in H 2 O 2 -treated LNCaP cells (Supplementary Figure 1D) . These data indicate that CPT inhibits proliferation of LNCaP cells, but does not induce apoptosis.
Since CPT did not induce apoptotic death in LNCaP cells, we examined the effect of CPT on the induction of autophagy. Western blot analysis showed that CPT significantly induced the expression of the autophagyrelated proteins, beclin-1, active LC3-II, and Atg-7, in a dose-dependent manner (Supplementary Figure 2A) at 24 h and in a time-dependent manner (Supplementary Figure 2B) , indicating that CPT promotes the expression of autophagy proteins in LNCaP cells. Furthermore, we examined whether autophagy regulates CPT-induced inhibition of cell viability. For the functional study of autophagy, we pretreated cells with 3-methyladenine (3MA) which inhibits LC3-I to LC3-II, and bafilomycin A1 (BAF), which blocks the fusion of autophagosomes and lysosomes in the presence of CPT. As sown, 3MA (0.6 mM) and BAF (20 nM) slightly decreased CPTinduced inhibition of cell viability (Supplementary Figure 2C) . Next, we determined whether autophagymediated decrease of cell viability was due to apoptosis in the presence of CPT. Our data indicated that combined treatment with CPT and 3MA significantly increased the annexin-V + cell populations, indicating that CPTinduced autophagy blocks the move into apoptotic death (Supplementary Figure 2D) . We also found that the ATM inhibitor suppressed CPT-induced Beclin-1 and LC3-II expression, suggesting that CPT-induced ATM promotes autophagy, resulting in protection against apoptosis (Supplementary Figure 2E) . Western blot analysis also confirmed that CPT decreased procaspase-3 and increased proapoptotic Bad in response to 3MA in human leukemia U937 cells (Supplementary Figure 2E) . Finally, 3MA-mediated inhibition of autophagy gradually increased DNA fragmentation in response to CPT in human leukemia U937 cells (Supplementary Figure 2F) . Taken together, these results indicate that CPT-induced autophagy blocks cell death and increases G 2 /M phase arrest. The cellular morphology was examined by light microscopy. Data from three independent experiments are shown as the overall mean ± S.E. Statistical signifi cance was determined by one-way ANOVA ( a p < 0.05 vs. untreated control).
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